These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362). Bergey JL; Sulkowski T; Much DR; Wendt RL Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506 [TBL] [Abstract][Full Text] [Related]
5. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs. Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760 [TBL] [Abstract][Full Text] [Related]
6. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system. Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380 [TBL] [Abstract][Full Text] [Related]
7. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251). Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767 [TBL] [Abstract][Full Text] [Related]
8. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent. Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107. Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441 [TBL] [Abstract][Full Text] [Related]
10. Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: a rationale for the short-term use of class I drugs against triggered arrhythmias. Takahara A; Sugiyama A; Hashimoto K Heart Vessels; 2004 Jan; 19(1):43-8. PubMed ID: 14685755 [TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic and hemodynamic effects of prifuroline. Benharkate M; Plassard G; Legeai J; Worcel M Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836 [TBL] [Abstract][Full Text] [Related]
12. Effects of the novel class Ia and class III antiarrhythmic agent RS-87337 on myocardial conduction in the anaesthetised dog. Allely MC; Alps BJ Arch Int Pharmacodyn Ther; 1988; 295():138-46. PubMed ID: 3245729 [TBL] [Abstract][Full Text] [Related]
13. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759 [TBL] [Abstract][Full Text] [Related]
14. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs. Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065 [TBL] [Abstract][Full Text] [Related]
15. Effects of RS-2135, a novel class I antiarrhythmic agent, on sustained ventricular tachycardia after coronary embolization in conscious dogs. Yorikane R; Mizuno H; Itoh Y; Miyake S; Koike H J Cardiovasc Pharmacol; 1994 Jul; 24(1):28-36. PubMed ID: 7521486 [TBL] [Abstract][Full Text] [Related]
16. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system. Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic effects of RS-2135, a new antiarrhythmic compound, on canine Purkinje fibers. Yorikane R; Sada T; Koike H J Cardiovasc Pharmacol; 1992 Dec; 20(6):955-60. PubMed ID: 1282599 [TBL] [Abstract][Full Text] [Related]
18. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity. Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195 [TBL] [Abstract][Full Text] [Related]
19. Effects of purified endogenous inhibitor of the Na+/Ca2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pig. Shpak B; Gofman Y; Shpak C; Hiller R; Boyman L; Khananshvili D Eur J Pharmacol; 2006 Dec; 553(1-3):196-204. PubMed ID: 17078946 [TBL] [Abstract][Full Text] [Related]
20. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs. Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]